ABSTRACI'. We evaluated the neuroprotective effect of lium in the conversion of L-arginine to L-citrulline by the enzyme the nitric oxide synthesis inhibitor, NC-nitro-L-arginine in NO synthase ( 9 , whose activity has also been reported in forea neonatal hypoxic-ischemic rat model. Unilateral hypoxic-brain homogenates (6). NMDA stimulates NO synthesis (7), and ischemic iqjury was produced in the brain of 7-dsld rats NO mediates glutamate neurotoxicity in vitro (8). NOARG, an using a combition of a common carotid artery ligation analog of L-arginine, competitively inhibits the enzymatic forand a hypoxic (8% oxygen) exposure for 2.5 h. In our mation of NO both in cultured endothelial cells (9) and cerebellar experimental condition, rectal temperatures did not differ homogenates (lo), also prevents neurotoxicity induced by between NC-nitro-L-argininetreated and salineinjected NMDA in cortical cultures (8), and easily crosses the blood-brain pups. We killed the animals 72 h later and assessed the barrier (10).
9
nine (2 mg/kg) administered intraperitoneally 1.5 h effect of NO synthesis inhibitors in adult models (1 1-16) be ore hypoxia resulted in 77% reduction of the infarcted prompted us to investigate whether NO was related to the genesis hemispheric volume and 87% reduction of the infarcted of cerebral hypoxic-ischemic brain damage in neonates. Sevenstriatal volume compared to saline injected controls. P -d-old rats were subjected to unilateral carotid artery ligation nitro-L-arginine given 1.5 h before the insult also signifi-followed by hypoxic exposure. This neonatal rat model shows cantly prevented hypoxic-ischemic damage in the five hip-infarction of the cerebral hemisphere ipsilateral to the carotid pocrunpal structures examined, dentate gyruq CA4, CA3, artery ligation (17) , and has been frequently used to investigate CAI, and subiculum. NG-nitro-L-arginine administered im-the pathogenesis of cerebral hypoxia ischemia (for review see mediately after hypoxia did not prevent hypoxic-ischemic Refs. 1 and 18). We investigated the neuroprotective effect of brain damage. These results indicate that nitric oxide plays NOARG administered before and after a hypoxic insult. a key role in producing neonatal hypoxic-ischemic brain damage. (Pediatr RPS 35: 10-14,1994)
MATERIALS AND METHODS

Abbreviations
We used the method of Rice et al. (17) to produce hypoxicischemic brain damage in neonatal rats. On the day of surgery, NMDA, N-methyl-aspa art ate Wister rat (Japan SLC, Inc.) littermates (the day of NO, nitric oxide birth is defined as d 1) were paired according to sex and body NOARC, NC-nitro-L-arginine weight (f0.5 g), each pair consisting of a pup assigned to NOARG treatment and a saline-injected control. If one member of a pair died, the other member was discarded. Under ether anesthesia, the left carotid artery was exposed through a midline neck incision, doubly ligated, and severed between the two Hypoxia-ischemia increases the extracellular concentration of ligatures. After surgery, the rat pups were allowed to recover for endogenous excitatory amino acids, which trigger a cascade of 2.5 to 3.5 h, and at the same time were fasted for 3.5 h before biochemical events, such as protease, lipase, and protein kinase hypoxic exposure by separating them from their dams. C activation; free radical formation; and uncoupling of oxidative Hypoxic exposure was ct~hieved by placing littermates (8-10 phosphorylation within mitochondria via an increase in free pumps) in a 2.0-L air-tight plastic box submerged in a 37'C cfiosolic Ca2+; this cascade ultimately leads to neuronal death water bath and flushed for 2.5 h with a humidified 8% oxygen ( 1 ), MDA, a glutamate receptor ago& plays a major role in and 92% nitrogen mixture delivered at 1.1 L/min. After 1 h the production of hypoxic-ischemic brain damage in the imma-recovery in the 37-C water bath, they were returned to their ture rat. Among the excitatory amino acid agonists, intracerebral mothers until killed at the age of 10 dinjection of NMDA produces the greatest degree of brain injury The effect of NOARG was msessed in the two IYouPs, each in 74-old rats [for review see (2) ]. The hypoxic-ischemic brain consisting of pairs from at kist three litters. In the prehypoxic damage in immature rats is identical in appearance and time treatment group (group 1, n = 12 pairs), 2 mdkg of NOARG course to the cfiotoxic reaction to NMDA (3) . MK-801 [(+)-5-(Sigma Chemical CO., St. Louis, MO) was administered intramethyl-10,11-dihydro-5H-dibenzo[a1d]cyclohepten-5, 10-imine peritoneally 1.5 h before the h~x i c insult-The reason why we maleate], a noncompetitive NMDA antagonist, protects against chose the dose of 2 mdkg is that, in preliminary experiments, h xic-ischemic brain damage in neonatal rats (4 group (group 2, n = 12 pairs), 2 mg/kg of NOARG was given immediately after the cessation of hypoxia. Each experimental animal received NOARG dissolved in normal saline (5 mllkg), and its paired littermate was administered the same volume of normal saline.
In rats administered NOARG ( n = 8) or saline ( n = 8) 1.5 h before the hypoxic insult, each rat pup underwent rectal temperature monitoring from 1.5 h before hypoxia until 24 h after the cessation of hypoxia at 10 time points (1.5 and 0 h before hypoxia, 1.5 h after the start of hypoxia, 0, 0.5, 1, 2, 3, 4, and 24 h after hypoxia).
The rat pups were perfusion-fixed with 4% formaldehyde buffered to pH 7.40 72 h after the hypoxic-ischemic insult at 10 d of age. The pups were anesthetized with pentobarbital (50 mg/ kg) intraperitoneally, and perfused with heparinized saline followed by neutral-buffered formaldehyde solution via the left ventricle. Each pump was decapitated after perfusion, and the head was stored in the same fixative at 4°C for at least 16 h. Coronal blocks of the brain were processed in a graded series of ethanol and xylene. After embedding in paraffin wax, 8-rmthick coronal slices were sectioned every 200 pm and stained with hematoxylin-eosin.
Areas of hypoxic-ischemic damage were calculated at six coronal levels (4) selected according to a stereotaxic atlas of the 10-d-old rat brain (19). The coronal levels with longitudinal coordinate and anatomic structure were as follows: A 7.0 mm at the nucleus accumbens, A 5.6 mm at the caudate-putamen and the anterior commissure, A 4.4 mm at the globus pallidus, A 3.2 mm at the anterior tip of the dorsal hippocampus, A 2.0 mm at the middle of the dorsal hippocampus, and A 0.8 mm at the ventral hippocampus. All measurements of area were performed on maps of these six coronal levels, using an image analyzer (LUZEX-2D, Nikon Corporation, Japan) with a magnification factor of about 2200 pixels/mm2. The measurements included the cerebral cortex in all six coronal planes and the striatum in two coronal planes at A 5.6 mm and A 4.4 mm, and areas showing hypoxic-ischemic damage in the same region. The percent volume occupied by hypoxic-ischemic necrosis was obtained in the cortex and the striatum by dividing the sum of damaged areas ipsilateral to the carotid ligation by the sum of the contralateral areas of each structure.
The hypoxic-ischemic changes of five hippocampal structures, 
CEREBRAL CORTEX
animals was evaluated by two-tailed Fisher's exact probability g 10-test, and differences in body weight and rectal temperature were
-SALINE evaluated by two-tailed unpaired t test. The extent of the hypoxicischemic volume and area in the cortex and the striatum, and -NOARG that of the neuronal damage score in the hippocampus were not distributed normally; therefore, they were tested by the two-tailed Mann-Whitney U test. A probability of less than 0.05 was considered significant.
RESULTS
The mortality rates during hypoxia did not differ significantly 2- in the oups with prehypoxic treatment with NOARG (16.7%, temperatures did not differ between NOARG-and saline-pretreated pups at any points examined. Cortical and striatal lesions with hypoxic-ischemic changes were sharply demarcated and were easily delineated using the image analyzer. The percent volume of hypoxic-ischemic damage in the cerebral cortex and striatum ipsilateral to the carotid artery ligation relative to the contralateral cerebral cortex and striatum is shown in Table 1 . The mean percent volume of hypoxicischemic brain damage of the NOARG-pretreated pups showed 77% reduction in the cerebral cortex and 87% reduction in the striatum relative to that of the saline-injected controls. However,
there was no protective effect in the NOARG-post-treated pups, both in the cerebral cortex and the striatum (Table 1 ). The
STEREOTACTIC CO-ORDINATES (mm)
hypoxic-ischemic lesions in the ipsilateral hemisphere were dis- Fig. 2 . Amount (mm2) of hypoxic-ischemic necrosis in neonates in tributed, in order of decreasing damage intensity, in the cerebrum different coronal planes of the cerebral cortex and striatum in group 1 with preservation of a small rim of cortex dorsomedially, the in which NOARG was administered 1.5 h before the insult. There are hippocampus, the striatum, the corpus callosum, and the thalasignificant differences ( p < 0.01; Mann-Whitney U test) between saline-mus (Fig. I) , and when NOARG was effective, the protection injected controls and NOARG-treated pups in all coronal planes exam-was seen in all coronal sections examined both in the cerebral ined in both cerebral cortex and striatum. Data represent mean f SE cortex and the striatum (Fig. 2) . (n = 8 pairs).
Hypoxic-ischemic damage of the hippocampus in this current study was so severe that in some of the control rats these neurons dentate gyrus, CA4* CA39 and subiculum, in the showed widespread necrosis and were replaced by vacuoles. hippocampus in the plane at A 2.0 mm were assessed Pretreatment with NOARG attenuated the hypoxic-ischemic according to a semiquantitative 4-point scale (4): 0, no damage; neuronal damage in all five substructures of the ipsilateral h i p 1, rare to occasional eosinophilic neurons (approximately less especially in the dentate and the CAI region. than 10%); 2, moderate Wnber of eosino~hilic ~eurons ( a p No protective was observed with posthypoxic treatment proximately 10 to 50%); and 3, frequent eosinophilic neurons with NoARG in all five substructures (~~b l~ 2). (greater than 50%). Light microscopic examination was performed with the examiner blinded to the experimental protocol.
DISCUSSION
The mean value from ipsilateral hippocampi evaluated independently was obtained from each animal.
Our results demonstrate that, in the neonatal period, treatment Data are presented as mean f SE. The mortality rate of the with an inhibitor of NO synthesis before an episode of cerebral hypoxia-ischemia provides marked protection against brain damage. However, therapy started immediately after the cessation of hypoxia failed to protect against brain damage. These results indicate that NO synthesis in brain tissue plays a critical role in the development of neonatal hypoxic-ischemic brain damage. Glutamatergic innervation of the striatum (20) and density of NMDA binding sites in the hippocampus (21) peak at around the 7th postnatal day. This transient overinnervation coincides with the enhanced neurotoxicity of microinjected NMDA and the enhancement of hypobaric-ischemic damage in the immature rat brain (2, 22) . Activated NMDA receptors increase free cytosolic Ca2+, which stimulates NO synthase (23) with binding to calmodulin (24) . NO, which is a free radical gas in itself, rapidly reacts with superoxide to form the stable peroxynitrite anion. Once protonated, peroxynitrite decomposes and generates a strong oxidant with reactivity similar to that of the hydroxyl radical (25) . In the present model, prevention ofthe neurotoxicity of the formed free radicals after hypoxic-ischemic damage is one of the neuroprotective effects of the inhibitor of NO synthesis. Allopurinol decreases superoxide radicals by inhibition of xanthine oxidase, and can thereby reduce perinatal hypoxic-ischemic brain damage (26) .
Neuronal NADPH diaphorase-containing neurons, which are selectively preserved 1 wk after hypoxic-ischemic injury in neonatal pups (27) , are identical to NO synthase-containing neurons (28). NADPH diaphorase-containing neurons are also relatively resistant to damage by low concentrations of NMDA agonists (29). Why these neurons are selectively resistant to neurotoxic insults has not been fully elucidated. The diaphorase activity of NO synthase may be associated with this neuroprotection. In addition, NO synthase-containing neurons are enriched in manganese superoxide dismutase (30) which could be protective by removing a superoxide anion that produces a strong oxidant with NO. Alternatively, the present evidence, which indicates possible effects of NO in both oxidizing a redox modulatory site consisting of thiol groups on the NMDA receptor-channel complex (3 1) and decreasing NMDA-mediated increase in intracellular Ca2+ (32), may represent a feedback inhibitory mechanism for NO production. In the presence of high concentrations of NMDA agonists, NADPH diaphorase-containing neurons, which are the source of neurotoxic NO (33), can release large amounts of NO (34) to kill nearby neurons, and may consequently produce widespread neuronal damage (29).
Glyceraldehyde-3-phosphate dehydrogenase, an important enzyme in the glycolytic pathway, is inactivated by ADP-ribosylation induced by NO (35) . Because glucose supplementation is beneficial to the perinatal brain exposed to hypoxia-ischemia (36, 37) , in contrast to adult animals, inhibition of NO synthesis may preserve the glycolytic pathway during the hypoxic-ischemic insult and may ameliorate the ultimate brain damage. Alternatively, NO inhibits both mitochondrial enzymes including complex 1 (NAD[P]H:ubiquinone oxidoreductase), complex 2 (succinate:ubiquinone oxidoreductase) and aconitase leading to subsequent inhibition of mitochondrial respiration, and the ratelimiting enzyme in DNA replication, ribonucleotide reductase, leading to inhibition of DNA synthesis in the macrophage effector cells (38) . All of these enzymes have a catalytically active nonheme iron-sulfur center which binds to NO leading to intracellular iron loss. Therefore, NO could mediate cytotoxicity by inhibiting mitochondrial functions in the hypoxic-ischemic brain (present study), as well as that of macrophages (39). There are at least two distinct NO synthases. One is the constitutive, Ca2+/ calmodulin-dependent enzyme, which releases NO for short periods in response to receptor activation in neurons, endothelial cells (40), and possibly in astrocytes (41). The other is the inducible form, which is induced by immunological stimuli and synthesizes NO Ca2+ independently over a period of hours to days in macrophages (42). Both NO synthases are soluble, require NADPH, form citrulline as a coproduct, and are competitively inhibited by L-arginine analogs. Recently, it was elucidated that glial cells ofthe central nervous system could express an inducible form of NO synthase, which may contribute to hypoxic-ischemic brain damage (43). The reason why in several studies (13, 14, 16) it failed to protect the brain from the ischemic insult with Larginine analogs administered for a short time may be that the inducible form of NO synthase could not be inhibited completely. However, the reason why prehypoxic treatment with one dose of NOARG could protect against hypoxic-ischemic brain damage in our study is unknown.
A possible explanation for the lack of effect of NOARG administered after the insult is that NO synthase activated by hypoxic stimuli could not generate NO because of the lack of molecular oxygen, which both constitutive and inducible NO synthases incorporate into NO. However, NO synthases are at once fully activated upon return of the rat to room air, and can immediately generate a burst of NO, which cannot be blocked by NOARG. Effective levels of NOARG would not be reached because the peritoneal vascular beds are vasoconstricted and absorption is slow. The lack of posthypoxic effect of the NO synthase inhibitor is not in accord with the neuroprotective effect of posthypoxic treatment with the NMDA receptor antagonist, MK-801, in another neonatal rat model of hypoxic-ischemic brain damage (4) .
Hypothermia can reduce ischemic brain damage both in adult rats (44) and immature rats (45). Postischemic treatment with NOARG reduces the area of cerebral infarction in adult mice (1 1) and rats (12) subjected to middle cerebral artery occlusion. P-nitro-L-arginine methyl ester, an inhibitor of NO synthesis, could reduce body temperature. When the body temperature was maintained at 37"C, nF-nitro-L-arginine methyl ester administered 30 min before and 30 min after middle cerebral artery occlusion could not protect against ischemic damage in the cerebral hemisphere (13) . In our study, each pup administered either NOARG or saline was kept in an atmosphere maintained at 37' C from soon after carotid arterv lieation to 1 h after the hypoxic insult. There were no signikca;t differences in rectal temperature between NOARG-and saline-pretreated pups from the time of treatment until 24 h after the cessation of hypoxic exposure. Therefore, the possible induction of hypothermia by NOARG is not able to explain its protective effect in this model of neonatal hypoxic-ischemic brain damage.
NOARG is reported to cause a pressor effect and bradycardia (46), and to decrease cerebral blood flow (47). It is not feasible to cannulate vessels in these small animals; therefore, whether circulatory effects of NOARG contribute to the neuroprotection is not clear. The arginine analogs could also inhibit the mitochondrial electron transport system by inhibiting the reduction of ferric cytochrome C (48). However, if NOARG had decreased the cerebral blood flow and inhibited the mitochondrial electron transport, it could have worsened the brain damage in our model.
